Registry collecting data on patients undergoing partial nephrectomy for kidney tumors
German National Registry for Nephron-Sparing Surgery
Association of Urologic Oncology (AUO) · NCT04681690
This study is collecting information from patients who are having surgery to remove part of their kidney due to tumors to see how different factors affect their care and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Association of Urologic Oncology (AUO) (other) |
| Locations | 5 sites (Hof, Bavaria and 4 other locations) |
| Trial ID | NCT04681690 on ClinicalTrials.gov |
What this trial studies
The G-NeSS Registry is an observational study that collects prospective data on clinical and outcome variables from patients who are undergoing partial nephrectomy for localized renal masses. The study aims to analyze key factors that influence the quality of surgical care in this population, focusing on variables such as patient characteristics, tumor complexity, and surgical approach. Follow-up assessments are conducted at various intervals to gather long-term data on kidney function and patient outcomes. This comprehensive data collection will help refine surgical practices and improve patient care in the treatment of kidney neoplasms.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with localized renal masses suitable for nephron-sparing surgery.
Not a fit: Patients with urothelial cancer of the kidney or those who have previously undergone nephron-sparing surgery on the same kidney may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved surgical techniques and better patient outcomes for those undergoing nephron-sparing surgery.
How similar studies have performed: Other studies have shown success in utilizing registries to improve surgical outcomes, making this approach both relevant and promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Written informed consent * Localized renal parenchymal mass amenable to nephron-sparing surgery * Adequate imaging of the abdomen (CT or MR with contrast) Exclusion Criteria: * Patient with (or suspected to have) urothelial cancer of the kidney * Prior nephron-sparing surgery on ipsilateral kidney * metastasized renal cell carcinoma
Where this trial is running
Hof, Bavaria and 4 other locations
- Sana Klinikum Hof — Hof, Bavaria, Germany (RECRUITING)
- MHH — Hanover, Lower Saxony, Germany (RECRUITING)
- Alexianer St. Hedwig-Krankenhaus — Berlin, Germany (RECRUITING)
- Vivantes Humboldt Klinikum — Berlin, Germany (RECRUITING)
- Saarland University — Homburg/Saar, Germany (NOT_YET_RECRUITING)
Study contacts
- Study coordinator: Nina Harke, Dr.
- Email: harke.nina@mh-hannover.de
- Phone: 0511/532
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Kidney Neoplasm